Strontium ranelate (Protos) for postmenopausal osteoporosis

Published in NPS RADAR

Date published: About this date

Clinical content may change after this date. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment.

New information relevant to this topic has become available since the RADAR review was published in November 2007.

Links to some relevant resources are provided below.




TGA-approved Product Information

Strontium ranelate (Protos), last amended 18 July 2008

July 2008

Australian guidelines

Clinical guideline for the prevention and treatment of osteoporosis in post-menopausal women and older men

February 2010

Australian Adverse Drug Reactions Bulletin

Severe skin reactions and venous thromboembolism with strontium ranelate (Protos) (Volume 27, Number 3)

June 2008

Other NPS  publications about osteoporosis drugs